Cookie Policy: This site uses cookies to improve your experience. You can find out more about our use of cookies in our Privacy Policy. By continuing to browse this site you agree to our use of cookies.
BioViotica
Undecylprodigiosin
100
CHF
CHF 100.00
In stock
BVT-0422-C250250 µgCHF 100.00
BVT-0422-M0011 mgCHF 305.00
Product Details | |
---|---|
Synonyms | Undecylprodiginine; Prodigiosin 25C |
Product Type | Chemical |
Properties | |
Formula |
C25H35N3O . HCl |
MW | 393.6 . 36.5 |
CAS | 56247-02-0 | 52340-48-4 (parent) |
Source/Host Chemicals | Isolated from Streptomyces parvulus. |
Purity Chemicals | ≥95% (HPLC, NMR) |
Appearance | Red solid. |
Solubility | Soluble in DMSO, methanol, acetone or chloroform. |
Identity | Determined by 1H-NMR. |
Declaration | Manufactured by BioViotica. |
InChi Key | ZZRPZWXEPLULCE-XWASNXTISA-N |
Smiles | COC1=CC(C2=CC=CN2)=N/C1=C\C3=CC=C(CCCCCCCCCCC)N3.Cl |
Shipping and Handling | |
Shipping | AMBIENT |
Short Term Storage | +4°C |
Long Term Storage | -20°C |
Handling Advice | Protect from light. |
Use/Stability |
Stable for at least 1 year after receipt when stored at -20°C. Store solutions at -20°C in the dark. |
Documents | |
MSDS | Download PDF |
Product Specification Sheet | |
Datasheet | Download PDF |
Description
- Tripyrrolic pigment like prodigiosin.
- Antimalarial agent.
- Apoptosis inducer.
- Anticancer agent with multiple modes of action.
- Immunosuppressant in non-toxic concentrations.
- Bone resorption inhibitor.
- Antiulcer agent.
Product References
- A new prodiginine (prodigiosin-like) pigment from Streptomyces. Antimalarial activity of several prodiginines: N. N. Gerber; J. Antibiot. 28, 194 (1975)
- Undecylprodigiosin: H. H. Wassermann, et al.; Tetrahedron 32, 1851 (1976)
- Characterization of the new immunosuppressive drug undecylprodigiosin in human lymphocytes: retinoblastoma protein, cyclin-dependent kinase-2, and cyclin-dependent kinase-4 as molecular targets: S. Songia, et al.; J. Immunol. 158, 3987 (1997)
- Chemistry and biology of roseophilin and the prodigiosin alkaloids: a survey of the last 2500 years: A. Fürstner; Angew. Chem. Int. Ed. 42, 3582 (2003)
- The prodigiosins: a new family of anticancer drugs: B. Montaner & R. Pérez-Tomás; Curr. Cancer Drug Targets 3, 57 (2003) (Review)
- Potent in vitro anticancer activity of metacycloprodigiosin and undecylprodigiosin from a sponge-derived actinomycete Saccharopolyspora sp. nov: R. Liu, et al.; Arch. Pharm. Res. 28, 1341 (2005)
- The biosynthesis and regulation of bacterial prodiginines: N. R. Williamson, et al.; Nat. Rev. Microbiol. 4, 887 (2006) (Review)
- Undecylprodigiosin selectively induces apoptosis in human breast carcinoma cells independent of p53: T.-F. Ho, et al.; Toxicol. Appl. Pharmacol. 225, 318 (2007)
- Prodigiosin synthesis with electron rich 2,2`-bipyrroles: B. Jolicoeur & W. D. Lubell; Can. J. Chem. 86, 213 (2008)
- Antimalarial activity of natural and synthetic prodiginines: K. Papireddy, et al.; J. Med. Chem. 54, 5296 (2011)
- Streptomyces sp. JS520 produces exceptionally high quantities of undecylprodigiosin with antibacterial, antioxidative, and UV-protective properties: N. Stankovic, et al.; Appl. Microbiol. Biotechnol. 96, 1217 (2012)
- Undecylprodigiosin induced apoptosis in P388 cancer cells is associated with its binding to ribosome: P. Liu, et al.; PLoS One 8, e65381 (2013)
- Properties and applications of undecylprodigiosin and other bacterial prodigiosins: N. Stankovic, et al.; Appl. Microbiol. Biot. 98, 3841 (2014)
- Undecylprodigiosin conjugated monodisperse gold nanoparticles efficiently cause apoptosis in colon cancer cells in vitro: J. Nikodinovic-Runic, et al.; J. Mater. Chem. B: Mat. Biol. Med. 2, 3271 (2014)
- Stereochemistry and Mechanism of undecylprodigiosin Oxidative Carbocyclization to Streptorubin B by the rieske oxygenase RedG: D.M. Withall, et al.; JACS 137, 7889 (2015)
- The Streptomyces metabolite anhydroexfoliamycin ameliorates hallmarks of Alzheimer's disease in vitro and in vivo: M. Leiros, et al.; Neuroscience (Amsterdam, Netherlands) 305, 26 (2015)
- Biological effects of bacterial pigment undecylprodigiosin on human blood cells treated with atmospheric gas plasma in vitro: S. Lazovic, et al.; Exp. Toxicol. Pathol. 69, 55 (2017)